Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: A prospective, longitudinal study

European Respiratory Journal

Volumn 10, Issue 8, 1997, Pages 1742-1746

  Riise, G C ^a   Kjellstrom C ^a   Ryd, W ^a   Schersten H ^a   Nillsson, F ^a   Martensson G ^a   Andersson, B A ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Bronchiolitis; Eosinophils; Hyaluronan; Lung transplantation; Myelopewxidase; Rejection

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 8; METHYLPREDNISOLONE; MYELOPEROXIDASE;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; BRONCHIOLITIS; BRONCHOSCOPY; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS PNEUMONIA;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMANS; INFECTION; LONGITUDINAL STUDIES; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 0030816487     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10081742     Document Type: Article

References (27)

1. Heritier F, Madden B, Hodson ME, Yacoub M. Lung allograft transplantation: indications, preoperative assessment and postoperative management. Eur RespirJ 1992; 5: 1262-1278.
2. Bando K, Paradis I, Similo S, et al. Obliterative bronchiolitis after lung and heart-lung transplantation. J Thoracic Cardiovasc Surg 1995; 110: 4-14.
3. Yousem SA, Berry G, Brunt E, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Transplant 1990; 9: 593-601.
4. Yousem SA. Graft eosinophilia in lung transplantation. Hum Pathol 1992; 23: 1172-1177.
5. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713-716.
6. Kramer MR, Stoehr C, Whang JL, et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 1993; 12: 675-681.
7. Foster PF, Bhattacharyya A, Sankary HN, Coleman J, Ashmann M, Williams JW. Eosinophil cationic protein's role in human hepatic allograft rejection. Hepatology 1991; 13(6): 1117-1125.
8. Ten RM, Gleich GJ, Holley KE, Perkins JD, Torres VE. Eosinophil granule major basic protein in acute renal allograft rejection. Transplantation 1989; 47: 959-963.
9. Wells A, Larsson E, Tengblad A, et al. The localization of hyaluronan in normal and rejected human kidneys. Transplantation 1990; 50(2): 240-243.
10. Rao PN, Zeevi A, Snyder J, et al. Monitoring of acute lung rejection and infection by bronchoalveolar lavage and plasma levels of hyaluronic acid in clinical lung transplantation. J Heart Lung Transplant 1994; 13: 958-962.
11. Riise GC, Schersten H, Nilsson FN, Ryd W, Andersson B. Activation of eosinophils and fibroblasts assessed by eosinophil cationic protein and hyaluronan in BAL: association with acute rejection in lung transplant recipients. Chest 1996; 110: 89-96.
12. Schersten H, Hedner T. McGregor CGA, et al. Increased levels of endothelin-1 in bronchoalveolar lavage fluid of patients with lung allografts. J Thorac Cardiovasc Surg 1996; 111: 253-258.
13. Crowder MJ, Hand DJ. Analysis of repeated measures. London, Chapman and Hall, 1990.
14. Lautenschlager I, Willebrand Ev, Häyry P. Blood eosinophilia, steroids and rejection. Transplantation 1985; 40: 354-357.
15. Foster PF, Sankary HN, Williams JW. Study of eosinophilia and hepatic dysfunction as a predictor of rejection in human liver transplantation. Transplant Proc 1988; 20: 676-677.
16. de Groen PC, Kephart GM, Gleich GJ, Ludwig J. The eosinophil as an effector cell of the immune response during hepatic allograft rejection. Hepatology 1994; 20(3): 654-662.
17. Venge P, Dahl R, Fredens K, Peterson CGB. Epithelial injury by human eosinophils. Am Rev Respir Dis 1988; 138: S54-S57.
18. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
19. Almirall J, Campistol JM, Sole M, Andreu J, Revert L. Blood and graft eosinophilia as a rejection index in kidney transplant. Nephron 1993; 65(2): 304-309.
20. Butler DM, Vitti GF, Leizer T, Hamilton JA. Stimulation of hyaluronic acid levels of human synovial fibroblasts by recombinant human TNF-α, TNF-β, IL-1α and IL-1β. Arthritis Rheum 1988; 31: 1281-1289.
21. Wells A, Klareskog L, Lindblad S, Laurent T. Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells: a role for macrophage-derived factors. Arthritis Rheum 1992; 35: 391-396.
22. Hällgren R, Gerdin B, Tengblad A, Tufveson G. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats. J Clin Invest 1990; 85(3): 668-673.
23. Richman-Eisenstat JBY, Jorens PG, Hebert CA, Ueki I, Nadel JA. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993; 264: L413-L418.
24. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1, interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049.
25. Clelland C, Higenbottam T, Stewart S, et al. Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Am Rev Respir Dis 1993; 147: 1386-1392.
26. Whitehead BF, Stoehr C, Wu CJ, et al. Cytokine gene expression in human lung transplant recipients. Transplantation 1993; 56: 956-961.
27. Baz MA, Tapson VF, Roggli VL, Trigt PV, Piantadosi CA. Glutathione depletion in epithelial lining fluid of lung allograft patients. Am J Respir Crit Care Med 1996; 153: 742-746.